Issue of Equity on exercise of warrants by dire...
7 December 2009
AVATION PLC
("Avation" or the "Company")
ISSUE OF SHARES
The Board of Avation announces that on the 3 December 2009, the Company issued and allotted 13,500
fully paid new ordinary shares pursuant to the exercise by Giant Mix Enterprises Limited. (a
company in which Mr. Baudinette, a director of Avation, has a beneficial interest) of options at a
price of 24.5p pence per ordinary share.
The Company also issued and allotted 50,000 fully paid ordinary shares in the Company at a price
of 24.5p pence per ordinary share to Bryant James McLarty as trustee for the McLarty Family A/C,
Mr McLarty is a director of the Company.
As a consequence there are now a total of 25,619,010 shares in issue and the Directors' interests
are now 17.5%. Mr Baudinette has a beneficial interest in 620,000 shares representing 2.42% of the
issued ordinary share capital of the Company. Mr McLarty has a beneficial interest in 57,300
shares representing 0.22% of the issued ordinary share capital of the Company.
---ENDS---
The directors take responsibility for the contents of this announcement.
ENQUIRES:
AVATION PLC 07783 942 553
Jeff Chatfield, Chairman
ADVISOR 020 7628 1128
Frank Lucas, Loeb Aron & Company
Avation plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.